Patients and caregivers report using medical marijuana to decrease prescription narcotics use

Humboldt Journal of Social Relations

Volumn 35, Issue 1, 2013, Pages 24-40

  Peters II, David C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Drugs; Gateway effect; Marihuana; Marijuana; Medical marijuana; Opiates

Indexed keywords

EID: 84900834742     PISSN: 01604341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Armentano, P. (2005). Marinol vs. Natural Cannabis: Pros, Cons and Options for Patients. NORML (National Organization for the Reformation of Marijuana Laws) available at: http://norml.org/index.cfm?Group-ID=6635: Accessed September 12, 2012.
2. Campbell, Fiona, Martin R Tramèr, Dawn Carroll, D John M Reynolds, R Andrew Moore, Henry J McQuay (2001). "Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review." British Medical Journal, 323:13.
3. Chase, J., Donovan, A. (1980). Psychosocial correlates of marijuana use and problem drinking in a national sample of adolescents. American Journal of Public Health 70, 604-610.
4. Consrue, P. Musty, R., Rein, J. et al (1997). The Perceived Effects of Smoked Cannabis on Patients with Multiple Sclerosis. Eur Neurol 38 (1).
5. DEA (2011). The DEA Position on Marijuana. Accessed September 12, 2011 available at: http://www.justice.gov/dea/marijuana-position.pdf.
6. Earleywine, M. (2002). Understanding Marijuana: A New Look at the Scientific Evidence. Cary, North Carolina: Oxford University Press.
7. Fergusson, D., Lynskey, M. & Horwood, L. J. (1997). The short term consequences of early cannabis use. Journal of Abnormal Child Psychology. 24:499-512.
8. Fergusson, D., Boden, J., Horwood, J. (2006). Cannabis Use and Other Illicit Drug Use: Testing the Gateway Hypothesis. Addiction. 101:4 556-569.
9. Golub, A., Johnson, B. (1994). The Shifting Importance of Alcohol and Marijuana as Gateway Substances. J. Stud. Alcohol 55:607-614.
10. Grant, I., Atkinson, J., Gouaux, B. (2012). Medical Marijuana: Clearing Away the Smoke. Open Neurol J. 6:18-25.
11. Hall, W., Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 375:9710 (196-197).
12. Kandel, D, Yamaguchi, K. Cousino-Klein, L. (2006). Testing the Gateway Hypothesis. Addiction, 101:4 (470-472).
13. LAR (2012). State of Michigan Licensing and Regulation Bureau. Medical Marijuana Program. Available at: http://www.michigan. gov/lara/0, 4601, 7-154-35299-28150-51869-, 00.html accessed September 13, 2012.
14. Lenza, M. (2007). Toking their way sober: Alcoholics and marijuana as folk medicine. Contemporary Justice Review, 10 (3) 307-322.
15. Lucas, P., Reiman, A., Earleywine, M., McGowan, S. Oleson, M., Coward, M. (2012). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory: 1-8; Early edition posted online on 20 Nov. 2012 at: http://informahealthcare.com.proxy.lib.wayne.edu/toc/art/0/0
16. Mich. Compiled Laws Chapter 333 §26421 - Chapter 333 §26430 (Michigan Medical Marijuana Act).
17. Robbins, M., Tarshis, S., Solomon, S., Grosberg B. (2009). Cluster Attacks Responsive to Recreational Cannabis and Dronabinol. Headache: The Journal of Head and Face Pain 49 (6) 914-916.
18. Scher, J. (1971). Marijuana as an agent in rehabilitating alcoholics (letter to the editor). Amer. J. Psychiat. 127:7-2.
19. Thompson, J., & Proctor, R. (1953). Pyrahexyl in the treatment of alcoholic and drug withdrawal conditions. N. Carolina Med. J. 14:520-523.
20. Todaro, B. (2012). "Cannabinoids in the Treatment of Chemotherapy-Induced Nausea and Vomiting." J. Natl Compr. Cancer Netw. 10:487-492.